First case report of Talaromyces marneffei infection in HIV-infected patient in the city of Ouagadougou (Burkina Faso)

Kiswendsida Thierry Guiguemde; Patindoilba Marcel Sawadogo; Adama Zida; Mamadou Cisse; Ibrahim Sangare; Sanata Bamba

doi:10.1016/j.mmcr.2019.09.003

First case report of Talaromyces marneffei infection in HIV-infected patient in the city of Ouagadougou (Burkina Faso)

Med Mycol Case Rep. 2019 Sep 18:26:10-12. doi: 10.1016/j.mmcr.2019.09.003. eCollection 2019 Dec.

Authors

Kiswendsida Thierry Guiguemde^{1

2}, Patindoilba Marcel Sawadogo², Adama Zida², Mamadou Cisse³, Ibrahim Sangare³, Sanata Bamba³

Affiliations

¹ Medical Analysis Laboratory, Charles-De-Gaulle Pediatric University Hospital Center, Ouagadougou, Burkina Faso.
² Laboratory of Parasitology-Mycology, Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso.
³ Department of Parasitology-Mycology, Higher Institute of Health Sciences (INSSA), Bobo-Dioulasso, Burkina Faso.

Abstract

Talaromycosis is endemic in Southeast Asia and is commonly described in HIV-infected patients. We describe the first case of Talaromycosis in HIV-infected patient in Burkina Faso. This is an 83-year-old man with skin lesions on the right foot. The thick scales were used for the mycological examination. Microscopic examination of growth allowed isolation of Talaromyces marneffei in its yeast and mold forms. The patient was treated successfully with Itraconazole (400 mg/day) for 8 weeks.

Keywords: Burkina Faso; Talaromyces marneffei; Talaromycosis; dimorphic fungus.

Publication types

Case Reports